New insider activity at Protagonist Therapeutics ( (PTGX) ) has taken place on March 15, 2025.
In a notable series of transactions, Protagonist Therapeutics’ CFO, Asif Ali, sold 24,903 shares of the company’s stock, amounting to a total of $1,462,553. Additionally, CMO Arturo MD Molina parted with 30,514 shares, generating $1,700,850 from the sale.
More about Protagonist Therapeutics
YTD Price Performance: 40.84%
Average Trading Volume: 876,988
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $3.54B
Questions or Comments about the article? Write to editor@tipranks.com